Kind Pharmaceuticals Llc
Clinical trials sponsored by Kind Pharmaceuticals Llc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill could replace needles for anemia in dialysis patients Results expected Oct 2026 (estimated)
- New pill AND019 takes on tough breast cancer in first human test Results expected Nov 2026 (estimated)
- New pill could replace shots for Kidney-Related anemia Results expected Dec 2026 (estimated)
- New pill could cut blood transfusions for MDS patients Results expected Dec 2026 (estimated)
- New pill could cut transfusions for thalassemia patients Results expected Dec 2026 (estimated)
-
New pill aims to boost red blood cells in cancer patients
Symptom relief Not yet recruitingThis Phase 2 trial tests an oral drug called AND017 for anemia (low red blood cells) in cancer patients who are not receiving chemotherapy. The study will enroll 36 participants to see if different doses of AND017 can safely raise hemoglobin levels over 6 weeks. The goal is to re…
Phase 2 • Sponsor: Kind Pharmaceuticals LLC • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New pill aims to beat chemo fatigue: AND017 trial launches
Symptom relief Not yet recruitingThis Phase 2 trial tests an oral drug called AND017 for cancer-related anemia caused by chemotherapy. About 36 adults with non-myeloid cancers and low hemoglobin will take AND017 three times a week for 6 weeks. The goal is to see if it safely raises hemoglobin levels and reduces …
Phase 2 • Sponsor: Kind Pharmaceuticals LLC • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC